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The Authors Reply
To the Editor—In his letter, Dr Tomassi describes his study 
from Kaiser Permanente Southern California, in which 
the investigators “expectantly managed” 378 patients with 
high-grade anal dysplasia, demonstrating an incidence rate 
of 0.19% per patient-year for anal squamous cell carcinoma 
(SCC). This rate is lower than the rate we identified using 
the population-based cancer registries of the Surveillance, 
Epidemiology, and End Results (SEER) Program of the Na-
tional Cancer Institute. It must be emphasized that Dr To-
massi’s data derive from Kaiser Permanente billing codes, 
and therefore all included patients are medically insured. 
As Dr Tomassi states in his letter, surveillance of patients 
at high risk for anal SCC is provided by “general and colo-
rectal surgeons, infectious disease specialists, family medi-
cine and internal medicine physicians, and gynecologists.” 
The Kaiser Permanente data come from a large integrated 
managed care group that receives high marks for quality 
of care with an emphasis on preventive care and access to 
care. This likely represents a higher level of longitudinal 
care than most patients in the United States are fortunate e-
nough to receive. Our SEER data are derived from 34.6% of 
the US population, irrespective of insurance status, and are 
Data from different sources have different  applications: 
for a large healthcare system or insurance organization 
looking to allocate resources and determine policy for a 
population, we commend the use of the Kaiser data. For 
a surgical practitioner counseling his or her patients, we 
commend data such as our own.
We share with our crosstown colleagues the clinical 
conclusion that expectant management of HSIL is reason-
able, based on evidence and experience. We wonder if we 
can now call it San Diego rather than expectant manage-
ment, to use a sunnier and less pregnant term! We also 
share with everyone in the field, including advocates of 
HSIL ablation with whom we disagree, the conviction that 
people at high risk for anal cancer should be followed reg-
ularly by practitioners accustomed to examining the anus. 
Indurated or ulcerated lesions should be biopsied so that 
early stage cancers can be detected and cured.
Bard C. Cosman, M.D., M.P.H.
VA San Diego Healthcare System, San Diego, California
Sonia L. Ramamoorthy,  M.D.
Luis C. Cajas-Monson, M.D.
Division of Colon and Rectal Surgery
Department of Surgery
University of California San Diego School of Medicine
La Jolla, California 
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the most representative sample of the overall state of cancer 
care in this country. It also must be noted that SEER in-
cludes patients with any neoplasia, not just invasive cancers.
Importantly, although Dr Tomassi states that the Ka-
iser cohort is a “pure expectant management cohort,” he 
notes that “patients with grossly abnormal or symptomatic 
lesions” were treated with “punch biopsy, excisional biopsy, 
or fulguration.” It is unclear exactly what other treatments 
were rendered based on the data presented. In addition, 
Dr Tomassi describes general surveillance procedures for 
high-risk patients (“digital rectal examination and anosco-
py at interval times ranging from 3 to 12 months”), but the 
actual frequency and type of surveillance each patient re-
ceived was not recorded. Ultimately and most importantly, 
the accuracy of the codes for anal intraepithelial neoplasia 
(AIN) is also unclear. Although the investigators verified 
the abstracted data with Kaiser Permanente Southern Ca-
lifornia registries for HIV, anal SCC, and cervical cancer, 
there does not appear to be an equivalent registry for the 
validation of anal dysplasia diagnoses. In contrast, SEER 
is a curated cancer registry not based on billing data but 
rather standard pathology report abstraction and rigorous 
monitoring processes to ensure high-quality data.
We are pleased that our article has started such a rich 
discussion of the appropriate management and surveil-
lance of patients with high-grade anal dysplasia. With this 
new wealth of data, it is imperative to consider the advan-
tages and disadvantages of each data source, from single 
institutions to population-level databases, and billing 
data to cancer registries. Ultimately, although Dr Tomassi 
found a lower rate of subsequent anal SCC in patients with 
high-grade anal dysplasia than our study, we all agree that 
the rate is significant enough to warrant surveillance of 
patients with AIN III. None of our studies can identify the 
single best algorithm for surveillance, yet all our studies 
report concerning trends for patients with AIN.
Grace C. Lee, M.D.
Rocco Ricciardi, M.D.
Massachusetts General Hospital
Boston, Massachusetts
New Attempt to Reach a 
Common Sense in Pilonidal 
Sinus Therapy
To the Editor–The new Clinical Practice Guidelines of the 
American Society of Colon and Rectal Surgeons have now 
been published,1 and the team headed by Scott Steele can 
be congratulated on their extensive and meticulous work, 
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which addresses most of the questions associated with 
pilonidal sinus surgery, improving the original Society 
guidelines grossly.2 They acknowledge that stronger, ra-
zor-sharp cut hairs from the head (as seen in Figure 1), ac-
cumulating between the buttocks and piercing the healthy 
skin,3 may be the source of pilonidal sinus disease.4,5 We 
agree with the majority of conclusions in the guidelines, 
but several topics are controversial at best.
Depilation
The authors correctly point out that razor depilation in-
creases the long-term recurrence rate.6 So why do they rec-
ommend it, as it doubles the recurrence rate?
Occipital hair is found in the sinus nest; so why is inter-
gluteal depilation important nevertheless? Intergluteal hair 
is a powerful catching zone, where cut hair from the head is 
caught, retained, and waiting to be drilled into the healthy 
skin by regular muscular movements. Thus, depilation of the 
cranial intergluteal fold may reduce recurrence rate, because 
it decreases contact time. Depilation creams may harm the 
skin with alkaline ingredients, thus harming the natural bar-
rier. Here, laser is of interest. However, even a perfect laser 
depilation will not remove the cut hair per se, so no depila-
tion treatment alone will ever achieve a zero recurrence rate. 
This could have been emphasized by the authors.
Hygiene
We are not at all happy that the new guidelines still address 
hygiene.1 Speaking bluntly, this is an insult to our patients, 
who already suffer enough from their disease. The major-
ity of young adolescents who we treat are seen shortly after 
puberty, when they discover sexuality. Many of them take 
showers 1 to 2 times a day. It has been shown that nei-
ther long-standing pus, nor feces, nor urine promotes or 
exaggerates pilonidal disease.7 Regular bathing or shower-
ing may lower pilonidal recurrence, however,8,9 because it 
FIGURE 1. Scanning electron microscopy picture of a razor-sharp 
cut hair end (courtesy of Norbert Pütz, University of the Saarland, 
Homburg/Saar).
reduces the number of cut hair fragments (Fig. 1) in the 
intergluteal cleft. So, yes, showering and bathing are useful 
to remove cut hair and clean open wounds if present, but 
hygienic enforcement has no place in a national clinical 
practice recommendation, because it punishes a majority 
of patients for something that is not their fault.
Corrosive Substances
The idea of corrosive tract and nest obliteration is an ap-
pealing one, and the injection of radioactive substances 
such as Thorium X, Lipoidol, and fuming nitric acid has 
been tried in the past. It has been discarded though. Phe-
nol is commonly used in the Indo-Arab region but is for-
bidden in Germany because of its corrosive and potentially 
embryotoxic effects. Long-term recurrence rates are dis-
mal,10 with a 5-year recurrence rate for phenol in excess of 
40%.10 Differences in application (crystalline, gel, or fluid) 
and concentration (25%–80%)11 may have an influence 
on efficacy but are not addressed in the new guidelines.
Recurrence Rates
Unfortunately the authors of the guidelines cite Stansby 
for his extended follow-up and give recurrence rates of 0% 
to 11%.1 Stansby’s recurrence rate is 10 (15%) of 65 in pri-
mary open treatment and 12 (12%) of 104 in phenol treat-
ment after a mean 8 months of follow-up.12 Thus his (less 
than) 1-year recurrence rate is 12%, which is impressively 
higher than any other pilonidal sinus disease therapy’s 
1-year recurrence rate.10 In our opinion, durable healing is 
not present at all, and the strong recommendation based 
on moderate evidence should be reconsidered.
In conclusion, it is a daunting task to elaborate a clin-
ical practice guideline and to come to a sound conclusion. 
We thank Johnson et al1 for their substantial work and ef-
forts. Taking the above-mentioned remarks into account, 
their recommendations will be well received.
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considering its relative common incidence. Although the 
authors note concern regarding depilation and hygiene, as 
well as intriguing more novel therapies such as corrosive 
substances, we are subtly reminded about the paucity of 
high-quality literature on this topic. One of the difficulties 
in preparing these and most surgical guidelines is the in-
herent limitations in the primary source literature, along 
with the varying experience and outcomes of individual 
authors within their own personal series.
We are again reminded that the American Society of 
Colon and Rectal Surgeons’ Clinical Practice Guidelines 
(CPG) committee is charged with the task of identifying 
areas of colorectal surgery that require guidance for ev-
idence-based practice. The committee collects pertinent 
literature, reviews and grades it according to guidelines set 
out by the GRADE group, and applies it to specific stan-
dards of practice. We strive to assess the available literature 
on the topic of interest fairly, and present it in an unbiased 
fashion. The reference list is not meant to be all inclusive, 
but rather to be broad-based. Our goal is to provide guid-
ance to help the clinician formulate a treatment plan that 
is effective and safe for the individual patient. This will al-
ways require judgment on the part of the clinician.
We agree that recurrence rates in patients with piloni-
dal disease are a function of time, and that extended fol-
low-up is required. We also agree that there is a spectrum 
of response to both nonoperative and operative interven-
tions. In light the available literature and widespread re-
sults, the determination of causation versus association is 
difficult to delineate definitively. If the parameter is read 
carefully, there is no mention of poor hygiene as a cause 
of pilonidal disease. However, any and all skin wounds in-
cluding pilonidal should be subject to cleaning and proper 
hygiene to enhance healing. Regarding more novel thera-
pies, we await further experience with longer follow-up to 
make definitive recommendations.
We would like to thank Drs Doll and Luedi for their 
thoughtful commentary. As with all CPGs, as additional 
evidence comes to light, future CPGs will review the rel-
evant literature and adjust any recommendations as 
indicated.
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The Authors Reply
To the Editor—We appreciate the letter to the editor from 
Drs Doll and Luedi regarding the most recent update to 
the American Society of Colon and Rectal Surgeons’ Clini-
cal Practice Guidelines for the Management of Pilonidal Di-
sease.1 The authors raise the issue of attempting to reach 
a “common sense” approach in the management of pilo-
nidal sinus therapy. The authors have certain interest and 
expertise in the area; in fact, much of the information and 
articles they cite (many of their own work) were reviewed 
and/or cited by the Clinical Practice Guidelines committee 
for this update.
Specifically, the authors note the controversies in the 
management of pilonidal disease, somewhat interesting 
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